Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Company Info
Headquarters
Number of Employees
Revenue (in millions)
Contact Info
Visit Website
Tagline
Overview
Company Services
Site Information
Contributors
Contributions
Clinical Trials Representation
Leveraging Decentralized Clinical Trial Strategies to Reduce Health Care Disparities
PAO-03-24-CL-05
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
PAO-03-24-CL-03
Pediatric Clinical Trials
Pediatric Clinical Trials: Considerations for Enrollment and Retention
PAO-02-24-CL-04
Roundtable
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
PAO-12-23-RT-01
Sustainable Clinical Trials
Driving a Sustainable Future in Clinical Trials through Decentralized Trial Models
PAO-12-23-CL-05
Real-World Data
How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?
PAO-09-23-RT-01
Industry Wisdom
What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?
PAO-09-23-RT-02
Roundtable: Patient Centricity
How is an increased focus on patient-centric concerns influencing the way that you work?
PAO-07-23-RT-02
Disruptive Technology
What do you view as the most disruptive or transformational technology or development on the horizon?
PAO-01-23-RT-01
Decentralized Clinical Trial Design
Reducing the Challenges Sites Face when Implementing Decentralized Trials
PAO-11-022-CL-05
Facility Expansion
Thermo Fisher Scientific Expands Millersburg, Pa. Bioprocessing Manufacturing Site
PR-M02-22-14
Personalized and Precision Medicine
Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?
PAO-12-21-RT-01
M&A
Thermo Fisher Scientific Acquires PPD and Leverages Clinical
PAO-06-21-MA-01
Cell Therapy Manufacturing
Thermo Fisher Scientific and UCSF to Open Cell Therapy cGMP Manufacturing and Collaboration Center
PR-M05-21-017
M&A
Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization
M&A
Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization
PR-M04-21-016
Acquisition
Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep
PR-M11-20-035
Termination
Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement
PR-M08-20-NI-21
Partnership
Thermo Fisher Scientific to Co-develop a Global Companion Diagnostic for Low-grade Glioma with Agios Pharmaceuticals
PR-M06-20-NI-023
Partnership
Thermo Fisher Scientific and CSL Enter Strategic Partnership
PR-M05-20-NI-040
Diagnostic Testing
Thermo Fisher Scientific Response to COVID-19 Expands to Include New Serology Test
PR-M05-20-NI-017
COVID-19
Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19
PR-M03-20-NI-046
AAV Vector Production
Challenges to Process Validation for Viral Vectors
PAP-Q1-20-CL-002
M&A
Thermo Fisher Scientific to Acquire QIAGEN N.V.
PR-M03-20-NI-009
Partnership
Civica Rx Partners with Thermo Fisher Scientific to Develop and Manufacture Drugs with a History of Drug Shortages
PR-M01-20-NI-027
Funding
Arranta Bio Announces $82M in New Funding, and a Strategic Partnership with Thermo Fisher Scientific
PR-M10-19-NI-044
AAV Vector Production
Production of AAV Vectors Using Suspension Mammalian and Insect Cell Systems
PAP-Q3-19-CL-006
M&A
Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK
PR-M05-19-NI-051
M&A
Brammer Bio Purchased by Thermo Fisher Scientific
PAO-M03-19-NI-032
Award
Thermo Fisher Scientific Instruments Recognized by SelectScience
PR-M03-19-NI-071
Acquistion
Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing
PR-M03-19-NI-078
Market Expansion
Thermo Fisher Scientific to Invest $150 Million to Expand Pharma Services Capabilities
PR-M03-19-NI-056
DCAT '19
Highly Potent API and Sterile Capabilities Key to DCAT Week ‘19 Company Announcements
PAO-M03-19-NI-024
Ethical Business Practices
Q: Given the ongoing evolution of the pharma industry today, how does your organization incorporate ethical concerns into your business practices?
PAP-Q1-2019-NI-001
Artificial Intelligence
Q: What do you believe the role of artificial intelligence and other advanced technologies will be in driving the development of the pharmaceutical industry over the next decade?
PAP-Q1-2019-NI-002
Vaccine
Thermo Fisher Scientific to Support mRNA-based Vaccine Candidate Production for BioNTech
Collaboration
Torque and Thermo Fisher Scientific Announce Collaboration to Build State-of-the-Art Facility to Manufacture Torque's Deep-Primed T Cell Immunotherapies
PR-M02-19-NI-011
Appointment
Thermo Fisher Scientific Elects New Director to Board
PR-M11-18-NI-038
New Faciliy
Thermo Fisher Scientific Opens Newly Expanded Facility in Frederick, Md.
PR-M11-18-NI-004
Analytic Testing
Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins
PR-M11-18-NI-003
New Facility
Thermo Fisher Scientific Opens Newly Expanded Facility in Frederick, Md.
PR-M10-18-NI-103
Partnership
Spectrum Pharmaceuticals Enters into a Next-Generation Sequencing Companion Diagnostic Partnership with Thermo Fisher Scientific
PR-M05-18-NI-017
Strategic Collaboration
Thermo Fisher and Leica Collaborate to Develop Integrated Cryotomography Workflow Solution
PR-M05-18-NI-009
Biologics
Thermo Fisher Scientific Announces $50 Million Investment to Enhance Biologics Capabilities
PR-M04-18-NI-90
Oncology
Thermo Fisher Scientific Launches Oncomine Childhood Cancer Research Assay and Establishes International Childhood Oncology Network
PR-M04-18-NI-62
Cloud
Thermo Fisher Scientific Announces Its First Cloud-Enabled Biological Safety Cabinet
PR-M04-18-NI-48
Acquistion
Thermo Fisher Scientific Acquires IntegenX, Provider of Leading Rapid DNA Technology for Human Identification
PR-M03-18-NI-087
Facility
Thermo Fisher Scientific Announces Plans to Build State-of-the-Art Pharma Services Facility in Rheinfelden (Baden) Germany
PR-M03-18-NI-067
Innovation
Thermo Fisher Scientific Showcases New Solutions for Accelerating, Innovating and Enhancing Productivity in the Fab and Lab at SEMICON China 2018
PR-M03-18-NI-060
Award
Thermo Scientific Krios G3i Cryo-Electron Microscope Announced as 2018 Edison Awards Finalist
PR-M03-18-NI-039
Announcement
Thermo Fisher Scientific Named Company of the Year by SelectScience
PR-M03-18-NI-025
Innovation
Thermo Fisher Supplies Analytical Instruments to World Anti-Doping Agency Laboratory in South Korea
PR-M03-18-NI-011
Innovation
Thermo Fisher Scientific Innovations Offer Greater Connectivity and Ease of Use
PR-M03-18-NI-005
Award
Thermo Fisher Scientific Wins CiteAb 2018 Award for its Antibody Validation Initiative
PR-M02-18-NI-040
Launch
Thermo Fisher Scientific Launches Axiom Microbiome Array for Research
PR-M02-18-NI-032
Innovation
Thermo Fisher Scientific Receives Manufacturing Leaders' Innovation Award
PR-M02-18-NI-023
Laboratory
New, Automated UV-Visible Spectrophotometers are Designed for Today's Modern Lab
PR-M02-18-NI-002
Technology
Thermo Fisher Scientific Announces More Than 30 Orders for Ion GeneStudio S5 One Week After Debut
PR-M01-18-NI-067
Flexible Manufacturing
Thermo Fisher Scientific Designs Flexible Manufacturing Site for Flexion Therapeutics, Inc.
PR-M01-18-NI-041
CAR T
Thermo Fisher Gets Key Customer for Its Cell Therapy Activation Reagents
PAO-M01-18-NI-006
Drug Development
Thermo Fisher Scientific’s Patheon Division to Manufacture Nasal Formulation for Evoke Pharma
PAO-M12-17-NI-003
Partnership
Magnetic Bead Technology Activates Novartis’ CAR-T Therapy
PAO-M09-17-NI-007
Acquisition
Patheon Acquired by Thermo Fisher Scientific
PAO-M05-17-NI-016
Equipment
What’s Trending for Thermo Fisher?
PTV-M11-16-AP-010